Comparing clinical outcomes for a twelve-month trial of zotarolimus- and everolimus-eluting stents in patients with coronary artery disease: data from the THCRIC registry
Conclusions:
According to our results, it could be concluded that the difference in the rate of MACE between the ZES and EES groups was not statistically significant at 12-month follow up.
Source: Therapeutic Advances in Cardiovascular Disease - Category: Cardiology Authors: Poorhoseini, H. R., Kassaian, S. E., Hoseini, K., Saroukhani, S., Salarifar, M., Alidoosti, M., Nematipour, E., Haji-Zeinali, A. M., Amirzadegan, A., Seyyed Mohammadzadeh, M. H., Khadem Vatan, K., Aghajani, H., Sheikh Fathollahi, M., Farrokh-Eslamlou, H. Tags: Original Research Source Type: research